{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T04:14:50Z","timestamp":1743308090451,"version":"3.40.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00105-025-05486-0","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T15:07:00Z","timestamp":1742396820000},"page":"202-210","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemtherapie der Neurodermitis und Psoriasis im Kindes- und Jugendalter","Systemic therapy of atopic dermatitis and psoriasis in children and adolescents"],"prefix":"10.1007","volume":"76","author":[{"given":"Michael","family":"Sticherling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"5486_CR1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/all.14510","volume":"76","author":"I Agache","year":"2021","unstructured":"Agache\u00a0I, Song\u00a0Y, Posso\u00a0M et\u00a0al (2021) Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A\u00a0systematic review for the EAACI biologicals guidelines. Allergy 76:45\u201358","journal-title":"Allergy"},{"key":"5486_CR2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jamadermatol.2023.4846","volume":"160","author":"A Al-Janabi","year":"2024","unstructured":"Al-Janabi\u00a0A, Alabas\u00a0OA, Yiu\u00a0ZZN et\u00a0al (2024) Risk of Paradoxical Eczema in Patients Receiving Biologics for Psoriasis. JAMA Dermatol 160:71\u201379","journal-title":"JAMA Dermatol"},{"key":"5486_CR3","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41573-023-00735-0","volume":"22","author":"T Bieber","year":"2023","unstructured":"Bieber\u00a0T (2023) Disease modification in inflammatory skin disorders: opportunities and challenges. Nat Rev Drug Discov 22:662\u2013680","journal-title":"Nat Rev Drug Discov"},{"key":"5486_CR4","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jaad.2021.05.013","volume":"86","author":"CM Brumfiel","year":"2022","unstructured":"Brumfiel\u00a0CM, Patel\u00a0MH, Zirwas\u00a0MJ (2022) Development of psoriasis during treatment with dupilumab: A\u00a0systematic review. J\u00a0Am Acad Dermatol 86:708\u2013709","journal-title":"J Am Acad Dermatol"},{"key":"5486_CR5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/bjd.20689","volume":"186","author":"E Burden-Teh","year":"2022","unstructured":"Burden-Teh\u00a0E, Murphy\u00a0R, Gran\u00a0S et\u00a0al (2022) Identifying the best predictive diagnostic criteria for psoriasis in children (\u3008\u202f18\u00a0years): a\u00a0UK multicentre case-control diagnostic accuracy study (DIPSOC study). Br J Dermatol 186:341\u2013351","journal-title":"Br J Dermatol"},{"key":"5486_CR6","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1002\/ski2.29","volume":"1","author":"A Cunliffe","year":"2021","unstructured":"Cunliffe\u00a0A, Gran\u00a0S, Ali\u00a0U et\u00a0al (2021) Can atopic eczema and psoriasis coexist? A\u00a0systematic review and meta-analysis. Skin Health Dis 1:e29","journal-title":"Skin Health Dis"},{"key":"5486_CR7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaci.2019.09.031","volume":"145","author":"T Czarnowicki","year":"2020","unstructured":"Czarnowicki\u00a0T, He\u00a0H, Canter\u00a0T et\u00a0al (2020) Evolution of pathologic T\u2011cell subsets in patients with atopic dermatitis from infancy to adulthood. J\u00a0Allergy Clin Immunol 145:215\u2013228","journal-title":"J Allergy Clin Immunol"},{"key":"5486_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2018.10.032","volume":"143","author":"T Czarnowicki","year":"2019","unstructured":"Czarnowicki\u00a0T, He\u00a0H, Krueger\u00a0JG et\u00a0al (2019) Atopic dermatitis endotypes and implications for targeted therapeutics. J\u00a0Allergy Clin Immunol 143:1\u201311","journal-title":"J Allergy Clin Immunol"},{"key":"5486_CR9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1159\/000514581","volume":"237","author":"YX Dai","year":"2021","unstructured":"Dai\u00a0YX, Tai\u00a0YH, Chang\u00a0YT et\u00a0al (2021) Bidirectional Association between Psoriasis and Atopic Dermatitis: A\u00a0Nationwide Population-Based Cohort Study. Dermatology 237:521\u2013527","journal-title":"Dermatology"},{"key":"5486_CR10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/all.12268","volume":"69","author":"SC Dharmage","year":"2014","unstructured":"Dharmage\u00a0SC, Lowe\u00a0AJ, Matheson\u00a0MC et\u00a0al (2014) Atopic dermatitis and the atopic march revisited. Allergy 69:17\u201327","journal-title":"Allergy"},{"key":"5486_CR11","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/ijd.17100","volume":"63","author":"A Docampo-Sim\u00f3n","year":"2024","unstructured":"Docampo-Sim\u00f3n\u00a0A, Belinch\u00f3n\u00a0I, S\u00e1nchez-Pujol\u00a0MJ et\u00a0al (2024) Psoriasis dermatitis, a\u00a0common phenotype of early forms of both psoriasis and atopic dermatitis in children: A\u00a0prospective multicenter study. Int J Dermatol 63:1392\u20131397","journal-title":"Int J Dermatol"},{"key":"5486_CR12","first-page":"959","volume":"17","author":"L Eisert","year":"2019","unstructured":"Eisert\u00a0L, Augustin\u00a0M, Bach\u00a0S et\u00a0al (2019) S2k guidelines for the treatment of psoriasis in children and adolescents\u2014Short version part 2. J\u00a0Dtsch Dermatol Ges 17:959\u2013973","journal-title":"J Dtsch Dermatol Ges"},{"key":"5486_CR13","first-page":"856","volume":"17","author":"L Eisert","year":"2019","unstructured":"Eisert\u00a0L, Augustin\u00a0M, Bach\u00a0S et\u00a0al (2019) S2k guidelines for the treatment of psoriasis in children and adolescents\u2014Short version part 1. J\u00a0Dtsch Dermatol Ges 17:856\u2013870","journal-title":"J Dtsch Dermatol Ges"},{"key":"5486_CR14","doi-asserted-by":"crossref","unstructured":"Fania L, Moretta G, Antonelli F et\u00a0al (2022) Multiple Roles for Cytokines in Atopic Dermatitis: From Pathogenic Mediators to Endotype-Specific Biomarkers to Therapeutic Targets. Int J Mol Sci 23","DOI":"10.3390\/ijms23052684"},{"key":"5486_CR15","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/all.12112","volume":"68","author":"D Garmhausen","year":"2013","unstructured":"Garmhausen\u00a0D, Hagemann\u00a0T, Bieber\u00a0T et\u00a0al (2013) Characterization of different courses of atopic dermatitis in adolescent and adult patients. Allergy 68:498\u2013506","journal-title":"Allergy"},{"key":"5486_CR16","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths\u00a0CEM, Armstrong\u00a0AW, Gudjonsson\u00a0JE et\u00a0al (2021) Psoriasis. Lancet 397:1301\u20131315","journal-title":"Lancet"},{"key":"5486_CR17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/exd.13336","volume":"27","author":"E Guttman-Yassky","year":"2018","unstructured":"Guttman-Yassky\u00a0E, Krueger\u00a0JG, Lebwohl\u00a0MG (2018) Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment. Exp Dermatol 27:409\u2013417","journal-title":"Exp Dermatol"},{"key":"5486_CR18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1684\/ejd.2021.3963","volume":"31","author":"N Kirsten","year":"2021","unstructured":"Kirsten\u00a0N, Mohr\u00a0N, Maul\u00a0JT et\u00a0al (2021) Incidence of atopic conditions in people with psoriasis: a\u00a0population-based analysis. Eur J Dermatol 31:60\u201364","journal-title":"Eur J Dermatol"},{"key":"5486_CR19","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1111\/jdv.15213","volume":"33","author":"TA Kouwenhoven","year":"2019","unstructured":"Kouwenhoven\u00a0TA, Bronckers\u00a0I, Van De Kerkhof\u00a0PCM et\u00a0al (2019) Psoriasis dermatitis: an overlap condition of psoriasis and atopic dermatitis in children. J\u00a0Eur Acad Dermatol Venereol 33:e74\u2013e76","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5486_CR20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4103\/ijd.ijd_871_22","volume":"68","author":"Y Li","year":"2023","unstructured":"Li\u00a0Y, Liu\u00a0H, Zhang\u00a0F (2023) Biologics-Induced Immunophenotypic Cross-Switching in Patients with Psoriasis and Atopic Dermatitis. Indian J Dermatol 68:186\u2013191","journal-title":"Indian J Dermatol"},{"key":"5486_CR21","first-page":"e15814","volume":"35","author":"G Paolino","year":"2022","unstructured":"Paolino\u00a0G, Di Nicola\u00a0MR, Brianti\u00a0P et\u00a0al (2022) New onset atopic dermatitis and psoriasis in the same patients under biologic treatments: The role of systemic treatments as a\u00a0possible trigger. Dermatol Ther 35:e15814","journal-title":"Dermatol Ther"},{"key":"5486_CR22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/joim.13235","volume":"290","author":"A Sch\u00e4bitz","year":"2021","unstructured":"Sch\u00e4bitz\u00a0A, Eyerich\u00a0K, Garzorz-Stark\u00a0N (2021) So close, and yet so far away: The dichotomy of the specific immune response and inflammation in psoriasis and atopic dermatitis. J\u00a0Intern Med 290:27\u201339","journal-title":"J Intern Med"},{"key":"5486_CR23","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1007\/s13555-023-01000-3","volume":"13","author":"JI Silverberg","year":"2023","unstructured":"Silverberg\u00a0JI, Hong\u00a0HC, Calimlim\u00a0BM et\u00a0al (2023) Comparative Efficacy of Targeted Systemic Therapies for Moderate-to-Severe Atopic Dermatitis without Topical Corticosteroids: An Updated Network Meta-analysis. Dermatol Ther (Heidelb) 13:2247\u20132264","journal-title":"Dermatol Ther (Heidelb)"},{"key":"5486_CR24","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1159\/000530608","volume":"239","author":"Z Su","year":"2023","unstructured":"Su\u00a0Z, Zeng\u00a0YP (2023) Dupilumab-Associated Psoriasis and Psoriasiform Manifestations: A\u00a0Scoping Review. Dermatology 239:646\u2013657","journal-title":"Dermatology"},{"key":"5486_CR25","doi-asserted-by":"crossref","unstructured":"Tsai YC, Tsai TF (2022) Overlapping Features of Psoriasis and Atopic Dermatitis: From Genetics to Immunopathogenesis to Phenotypes. Int J Mol Sci 23","DOI":"10.3390\/ijms23105518"},{"key":"5486_CR26","first-page":"307","volume":"22","author":"T Werfel","year":"2024","unstructured":"Werfel\u00a0T, Heratizadeh\u00a0A, Aberer\u00a0W et\u00a0al (2024) S3 guideline Atopic dermatitis: Part\u00a02\u2014Systemic treatment. J\u00a0Dtsch Dermatol Ges 22:307\u2013320","journal-title":"J Dtsch Dermatol Ges"},{"key":"5486_CR27","first-page":"137","volume":"22","author":"T Werfel","year":"2024","unstructured":"Werfel\u00a0T, Heratizadeh\u00a0A, Aberer\u00a0W et\u00a0al (2024) S3 Guideline Atopic dermatitis: Part\u00a01\u2014General aspects, topical and non-drug therapies, special patient groups. J\u00a0Dtsch Dermatol Ges 22:137\u2013153","journal-title":"J Dtsch Dermatol Ges"},{"key":"5486_CR28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/jdv.14891","volume":"32","author":"A Wollenberg","year":"2018","unstructured":"Wollenberg\u00a0A, Barbarot\u00a0S, Bieber\u00a0T et\u00a0al (2018) Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J\u00a0Eur Acad Dermatol Venereol 32:657\u2013682","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5486_CR29","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/jdv.14888","volume":"32","author":"A Wollenberg","year":"2018","unstructured":"Wollenberg\u00a0A, Barbarot\u00a0S, Bieber\u00a0T et\u00a0al (2018) Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J\u00a0Eur Acad Dermatol Venereol 32:850\u2013878","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5486_CR30","first-page":"224","volume":"120","author":"A Wollenberg","year":"2023","unstructured":"Wollenberg\u00a0A, Werfel\u00a0T, Ring\u00a0J et\u00a0al (2023) Atopic Dermatitis in Children and Adults\u2014Diagnosis and Treatment. Dtsch \u00c4rztebl Int 120:224\u2013234","journal-title":"Dtsch \u00c4rztebl Int"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-025-05486-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-025-05486-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-025-05486-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T16:59:30Z","timestamp":1743267570000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-025-05486-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["5486"],"URL":"https:\/\/doi.org\/10.1007\/s00105-025-05486-0","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"type":"print","value":"2731-7005"},{"type":"electronic","value":"2731-7013"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"assertion":[{"value":"4 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Sticherling weist auf folgende Beziehungen hin. Forschungsunterst\u00fctzung, Vortrags- und Beratert\u00e4tigkeit, Teilnahme an klinischen Studien Abbvie, Almirall, Amgen, BMS, Boehringer Ingelheim, Janssen, Leo, Lilly, MSD, Novartis, Pfizer, Sandoz, Sanofi.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}